JENNIFER WEI: Open Payments
NPI 1568127215 · FRANKLIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,117 in 234 payments from 18 companies in 2025. Trend: 2023 $1,274 · 2024 $1,670 · 2025 $4,117
Food & beverage: $4,117
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 22 | $613 |
| Neurocrine BioSciences, Inc. | 18 | $471 |
| Alkermes, Inc. | 21 | $365 |
| E.R. Squibb & Sons, L.L.C. | 15 | $358 |
| Supernus Pharmaceuticals, Inc. | 39 | $326 |
| Otsuka America Pharmaceutical, Inc. | 17 | $320 |
| Axsome Therapeutics, Inc. | 12 | $286 |
| Janssen Pharmaceuticals, Inc | 13 | $235 |
| Teva Pharmaceuticals USA, Inc. | 13 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $188 |
Products named: INGREZZA, COBENFY, HETLIOZ, Qelbree, ARISTADA, Auvelity, REXULTI, FANAPT.
Industry payments across TN — which companies pay providers there.
